The retrospective study looked at 3,340 patients with cardiac surgery and in-hospital outcomes of postoperative mortality, new acute renal failure and perioperative blood transfusion.
Patients who received aprotinin were more often elderly and female. In-hospital mortality was significantly higher in the aprotinin group compared to the TXA group, up 5 percent. The ICU stay was also significantly increased in the aprotinin group, up 8.3 percent.
More Articles on Anesthesia:
Study: Type of General Anesthesia May Not Affect Risk of Myocardial Infarction
Anesthesiologist Dr. Rebecca Patchin to Serve as Joint Commission Board Chair
Marine Corps Searches for Smaller, More Rugged Anesthesia Machines
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
